Healthcare provider profile · identity verified

Robyn E Odzark, DO

Family Practice · SAVANNAH, GA · NPI 1326487703

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	462	159
Atorvastatin Calcium	Atorvastatin Calcium	453	159
Losartan Potassium	Losartan Potassium	253	97
Levothyroxine Sodium	Levothyroxine Sodium	226	69
Gabapentin	Gabapentin	210	92
Omeprazole	Omeprazole	177	61
Pantoprazole Sodium	Pantoprazole Sodium	174	69
Furosemide	Furosemide	173	70
Rosuvastatin Calcium	Rosuvastatin Calcium	161	62
Metformin Hcl	Metformin Hcl	158	55
Hydrochlorothiazide	Hydrochlorothiazide	153	58
Lisinopril	Lisinopril	149	50
Albuterol Sulfate Hfa	Albuterol Sulfate	141	60
Glipizide	Glipizide	123	45
Carvedilol	Carvedilol	121	47
Diclofenac Sodium	Diclofenac Sodium	113	66
Metoprolol Succinate	Metoprolol Succinate	112	45
Potassium Chloride	Potassium Chloride	111	43
Trulicity	Dulaglutide	110	24
Ozempic	Semaglutide	105	28
Tizanidine Hcl	Tizanidine Hcl	103	44
Metformin Hcl Er	Metformin Hcl	99	36
Triamcinolone Acetonide	Triamcinolone Acetonide	92	62
Pregabalin	Pregabalin	91	32
Farxiga	Dapagliflozin Propanediol	90	25
Trazodone Hcl	Trazodone Hcl	89	34
Fluticasone Propionate	Fluticasone Propionate	88	56
Pioglitazone Hcl	Pioglitazone Hcl	87	36
Montelukast Sodium	Montelukast Sodium	84	32
Meloxicam	Meloxicam	81	41
Famotidine	Famotidine	76	30
Methylprednisolone	Methylprednisolone	76	61
Tamsulosin Hcl	Tamsulosin Hcl	74	29
Ibuprofen	Ibuprofen	73	35
Allopurinol	Allopurinol	68	21
Linzess	Linaclotide	67	15
Oxybutynin Chloride Er	Oxybutynin Chloride	66	32
Duloxetine Hcl	Duloxetine Hcl	65	25
Tramadol Hcl	Tramadol Hcl	65	33
Alprazolam	Alprazolam	62	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	17
Eliquis	Apixaban	59	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	20
Prednisone	Prednisone	57	35
Simvastatin	Simvastatin	55	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	52	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	17
Fluconazole	Fluconazole	48	25
Hydralazine Hcl	Hydralazine Hcl	46	17
Spironolactone	Spironolactone	46	17
Alendronate Sodium	Alendronate Sodium	45	15
Clopidogrel	Clopidogrel Bisulfate	45	15
Bupropion Hcl Sr	Bupropion Hcl	44	15
Ezetimibe	Ezetimibe	44	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	15
Pravastatin Sodium	Pravastatin Sodium	44	17
Hydroxyzine Hcl	Hydroxyzine Hcl	43	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	20
Donepezil Hcl	Donepezil Hcl	40	14
Sertraline Hcl	Sertraline Hcl	40	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	12
Colchicine	Colchicine	39	22
Olmesartan Medoxomil	Olmesartan Medoxomil	39	15
Metoprolol Tartrate	Metoprolol Tartrate	37	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	30
Finasteride	Finasteride	36	13
Glipizide Er	Glipizide	36	15
Ondansetron Odt	Ondansetron	35	17
Celecoxib	Celecoxib	34	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	12
Escitalopram Oxalate	Escitalopram Oxalate	32	13
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Clobetasol Propionate	Clobetasol Propionate	30	18
Nystatin	Nystatin	30	11
Valsartan	Valsartan	30	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	19
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Azithromycin	Azithromycin	23	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	21
Doxycycline Monohydrate	Doxycycline Monohydrate	23	18
Meclizine Hcl	Meclizine Hcl	23	suppressed
Baclofen	Baclofen	22	11
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Jardiance	Empagliflozin	18	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	13
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Atenolol	Atenolol	16	suppressed
Cephalexin	Cephalexin	16	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Topiramate	Topiramate	13	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error